Topical Ofloxacin Treatment of Otorrhea in Children With Tympanostomy Tubes

Authors:
  • EGEric T. Garner
    Eric T. Garner
  • RNRichard W. Nielsen
    Richard W. Nielsen
  • MBMerril A. Biel
    Merril A. Biel
  • MSMindell Seidlin
    Mindell Seidlin

Abstract
BY CURRENT estimates, approximately 1 million children undergo tympanostomy tube insertions each year in the United States for the treatment of intractable middle ear effusions or repeated episodes of acute otitis media (AOM).1 Otorrhea occurs in 21% to 34% of all such children at some time after the tubes are in place.2 Unlike patients with AOM and intact tympanic membranes, children with tympanostomy tubes seldom have otalgia, fever, or other systemic signs of AOM without also having infections at other sites. Acute purulent otorrhea (draining ear) is the hallmark of AOM in the presence of tympanostomy tubes.

This publication has 12 references indexed in Scilit: